Loading…
Suven Life Sciences (SUVEN)₹279.95+2.06%Healthcare Research, Analytics & Technology
Suven Life Sciences has 12 dividends on record since 2010. The latest, an interim dividend of ₹1.50 per share, had an ex-date of 14 Feb 2019. No regular dividend went ex in the 12 months to 9 Nov 2026. Bonus issues: 2007.
As of · NSE / BSE corporate actions
| Ex-date | Type | Declared (₹/share) |
|---|---|---|
| 14 Feb 2019 | Interim | 1.50 |
| 6 Feb 2018 | Interim | 1.50 |
| 8 Feb 2017 | Interim | 1.00 |
| 14 Mar 2016 | Interim | 1.00 |
| 14 Mar 2016 | Special | 1.00 |
| 23 Jul 2015 | Final | 0.60 |
| 24 Jul 2014 | Final | 0.50 |
| 24 Jul 2014 | Special | 2.00 |
| 1 Aug 2013 | Final | 0.30 |
| 17 Sept 2012 | Final | 0.30 |
| 1 Aug 2011 | Final | 0.25 |
| 19 Jul 2010 | Final | 0.25 |
| Year | Dividends | Total (₹/share) |
|---|---|---|
| FY19 | 1 | 1.50 |
| FY18 | 1 | 1.50 |
| FY17 | 1 | 1.00 |
| FY16 | 3 | 2.60 |
| FY15 | 2 | 2.50 |
| FY14 | 1 | 0.30 |
| FY13 | 1 | 0.30 |
| FY12 | 1 | 0.25 |
| FY11 | 1 | 0.25 |
| Date | Action | Detail |
|---|---|---|
| 17 Oct 2022 | Rights issue | Rights Issue |
| 17 Oct 2022 | Rights issue | Rights 1:2 @ Premium Rs 54/- |
| 21 Jan 2020 | Demerger | Demerger |
| 23 Mar 2007 | Bonus issue | Bonus Issue Equity number of shares are based on the latest face value of Re.1/-each. |
| 6 Dec 2006 | Merger | Scheme of Arrangement/Amalgamation 3725000 shares have been allotted to the shareholders of erstwhile Asian Clinical Trials Ltd pursuant to the scheme of amalgamation. |
Yes. Suven Life Sciences has 12 dividends on record; no regular dividend went ex in the 12 months to 9 Nov 2026.
Interim dividend of ₹1.50 per share, with an ex-date of 14 Feb 2019.
Suven Life Sciences paid 1 dividend with ex-dates in FY19 (April to March), totalling ₹1.50 per share on today's share count basis.
Suven Life Sciences has no dividend yield in our data for the last twelve months.
Yes: a bonus issue with an ex-date of 23 Mar 2007.